Moderna (MRNA) Assets Growth (3y) (2020 - 2026)
Moderna (MRNA) Assets Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Moderna |
25.27 Bn |
20.06 Bn |
-566.00 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-21.91% |
| Dec 31, 2025 |
-21.86% |
| Sep 30, 2025 |
-22.49% |
| Jun 30, 2025 |
-22.74% |
| Mar 31, 2025 |
-22.80% |
| Dec 31, 2024 |
-16.93% |
| Sep 30, 2024 |
-8.93% |
| Jun 30, 2024 |
-0.99% |
| Mar 31, 2024 |
9.64% |
| Dec 31, 2023 |
35.93% |
| Sep 30, 2023 |
61.11% |
| Jun 30, 2023 |
84.47% |
| Mar 31, 2023 |
126.81% |
| Dec 31, 2022 |
153.39% |
| Sep 30, 2022 |
153.95% |
| Jun 30, 2022 |
149.08% |
| Mar 31, 2022 |
148.18% |
| Dec 31, 2021 |
132.53% |
| Dec 31, 2020 |
89.13% |
